Neurogene Inc. · NASDAQ:NGNE
Trails Edge Capital Partners, LP's stake in Neurogene Inc. fell to 4.50% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Trails Edge Capital Partners, LP's stake in Neurogene Inc. fell to 4.50%, 714,885 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 4.50%
- Shares
- 714,885
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Trails Edge Capital Partners, LP | 4.50% | 714,885 |
| Trails Edge Biotechnology Master Fund, LP | 4.50% | 714,885 |
| Ortav Yehudai | 4.50% | 714,885 |
Source
Related
- Neurogene Inc.
- Trails Edge Capital Partners, LP
- Neurogene Inc. shareholders
- Schedule 13G · Trails Edge Capital Partners, LP · Dec 15, 2025
- Schedule 13G · Prudential Financial Inc · Oct 7, 2026
- Schedule 13G · Jennison Associates LLC · Oct 6, 2026
- Form 4 · McMinn Rachel · Oct 2, 2026
- Schedule 13G/A · Redmile Group, LLC · Aug 14, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026